Yiting Wang
Nanchang University
9 Papers
3 Citations
Yiting Wang is an academic researcher from Nanchang University. The author has contributed to research in topics: Oncogene & Hedgehog signaling pathway. The author has an hindex of 5, co-authored 9 publications.
Chat about Author
Papers
FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
Guohui Hu,Zhengwei Yan,Cheng Zhang,Minzhang Cheng,Yehong Yan,Yiting Wang,Libin Deng,Quqin Lu,Shiwen Luo +8 more
TL;DR: The FOXM1–KIF4A axis mediates human HCC progression and is a potential therapeutic target for HCC treatment.
GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells.
Dengliang Huang,Yiting Wang,Linlin Xu,Limin Chen,Minzhang Cheng,Wei Shi,Huanting Xiong,Detina Zalli,Shiwen Luo +8 more
TL;DR: These results suggest that therapeutic strategies targeting the GLI2/ARHGEF16/CKAP5 signaling axis could inhibit glioma progression and recurrence.
FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells.
Bei Yu,Linlin Xu,Limin Chen,Yao Wang,Hongying Jiang,Yiting Wang,Yehong Yan,Shiwen Luo,Zhenyu Zhai +8 more
TL;DR: It is shown that ARHGEF16 was highly expressed in clinical specimens of colon cancer and a nonreceptor tyrosine kinase, FYN, as a novel partner of ARH GEF16, which mediates colon cancer progression and is a potential therapeutic target for colon cancer treatment.
The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation
Yiting Wang,Hailong Wang,Zhengwei Yan,Guohua Li,Guohui Hu,Hong Zhang,Dengliang Huang,Yao Wang,Xiang Zhang,Yehong Yan,Quqin Lu,Minzhang Cheng,Shiwen Luo +12 more
TL;DR: TPX2 acts as a novel downstream target and effector of the Hh pathway, and Hh signaling contributes to HCC proliferation via regulating the FOXM1- TPX2 cascade, suggesting that this signaling axis may be a novel therapeutic target for HCC.
QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.
Yaqi Li,Mei Liu,Zhuoxian Zhang,Libin Deng,ZhenYu Zhai,Hua Liu,Yiting Wang,Cheng Zhang,Jianping Xiong,Chao Shi +9 more
TL;DR: In this article, the expression pattern and prognostic significance of Quiescin Q6 sulfhydryl oxidase 2 (QSOX2) in non-small cell lung cancer (NSCLC) and its role in tumor growth remains unclear.